Penn Medicine Abramson Cancer Center
A

Penn Updates on RT in Lung Cancer During COVID-19: SBRT vs. Surgery, Antimicrobial Therapy + SBRT in Early Stage NSCLC, Benefits of Proton Therapy

By Penn Medicine Abramson Cancer Center FEATURING Abigail Berman
By Penn Medicine Abramson Cancer Center FEATURING Abigail Berman
87 views
March 18, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
35:40
Balazs Halmos

Year in Review: Lung Cancer

17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
27:04
Fengting Yan

Cancer Screening Molecular Tools

25:35
Total Health

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Feat. S. Kazmi
08:49
David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

30:27
Insights from 2023 ESMO Annual Meeting

Perioperative Immunotherapy Strategies in Resectable NSCLC After ESM…

Feat. G. Mountzios
07:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…

Feat. J. West
16:12
Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon
05:02
GRACE

Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC

Feat. A. Desai
23:32
2023 West Oncology Conference

2023 Updates on Neoadjuvant and Adjuvant NSCLC

Feat. M. Johnson
11:50
GRACE

The CheckMate 816 Trial: The Success of Neoadjuvant NSCLC Therapies

Feat. J. Rotow
22:57
Total Health

Lung Cancer Screening - Best of Lung 2023

Feat. C. Olazagasti
20:27
Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst
54:26
Yale Cancer Center

Year in Review: Progress in NSCLC Treatment

Feat. R. Herbst
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

23:36
CHEST 2022 Coverage

Immune Checkpoint Inhibitor Pneumonitis in Lung Cancer

Feat. J. Possick
21:24
Chul Kim

ADCs and Bispecific Inhibitors in NSCLC

08:15
ecancer

ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"

Feat. B. Gyawali
03:44
ecancer

ASCO® 2023 Insights: "Dr. Wakelee on KEYNOTE-671 Study Updates …

Feat. H. Wakelee